BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 12564292)

  • 1. [Atherosclerosis and inflammation: the role of C-reactive protein].
    Ablij HC; Meinders AE
    Ned Tijdschr Geneeskd; 2003 Jan; 147(1):15-20. PubMed ID: 12564292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity C-reactive protein is the most effective prognostic measurement of acute coronary events.
    Futterman LG; Lemberg L
    Am J Crit Care; 2002 Sep; 11(5):482-6. PubMed ID: 12233975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of inflammation in the pathogenesis of atherosclerosis].
    Banach M; Markuszewski L; Zasłonka J; Grzegorczyk J; Okoński P; Jegier B
    Przegl Epidemiol; 2004; 58(4):663-70. PubMed ID: 15810508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel role of C-reactive protein in cardiovascular disease: risk marker or pathogen.
    Wilson AM; Ryan MC; Boyle AJ
    Int J Cardiol; 2006 Jan; 106(3):291-7. PubMed ID: 16337036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M; Keren A; Banai S
    Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inflammation, atherosclerosis and acute coronary syndromes].
    Biasucci LM; Santamaria M; Liuzzo G
    Minerva Cardioangiol; 2002 Oct; 50(5):475-86. PubMed ID: 12384630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease].
    Piechota W; Piechota W
    Pol Merkur Lekarski; 2005 May; 18(107):511-5. PubMed ID: 16161944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.
    Li JJ; Fang CH
    Med Hypotheses; 2004; 62(4):499-506. PubMed ID: 15050096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein. Should it be considered a coronary risk factor?
    Aronow WS
    Geriatrics; 2003 May; 58(5):19-22, 25. PubMed ID: 12756677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein: a new golden marker of cardiovascular risk.
    Gomes MC
    Rev Port Cardiol; 2002 Nov; 21(11):1329-46. PubMed ID: 12564084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
    Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
    Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pro-inflammatory and anti-inflammatory markers in coronary artery disease and acute ischemic coronary syndrome].
    Fragoso-Lona JM; Ramírez-Bello J; Cruz-Robles D; Pérez-Méndez O; de la Peña A; Vargas-Alarcón G
    Arch Cardiol Mex; 2009; 79(1):54-62. PubMed ID: 19545076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and its role in the pathogenesis of myocardial infarction.
    Pepys MB; Hirschfield GM
    Ital Heart J; 2001 Nov; 2(11):804-6. PubMed ID: 11770862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TH1/TH2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines--immunological alterations in acute coronary syndrome and stable coronary artery disease.
    Szodoray P; Timar O; Veres K; Der H; Szomjak E; Lakos G; Aleksza M; Nakken B; Szegedi G; Soltesz P
    Scand J Immunol; 2006 Sep; 64(3):336-44. PubMed ID: 16918703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of C-reactive protein and other acute phase markers in atherosclerosis].
    Gusev DE; Ponomar' EG
    Klin Med (Mosk); 2006; 84(5):25-30. PubMed ID: 16827274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute coronary syndrome and inflammation. Biomarkers for diagnostics and risk stratification].
    Trepels T; Zeiher AM; Fichtlscherer S
    Herz; 2004 Dec; 29(8):769-76. PubMed ID: 15599673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans.
    Lehrke M; Millington SC; Lefterova M; Cumaranatunge RG; Szapary P; Wilensky R; Rader DJ; Lazar MA; Reilly MP
    J Am Coll Cardiol; 2007 Jan; 49(4):442-9. PubMed ID: 17258089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein and atherosclerosis: quo vadis?
    Koenig W; Torzewski J
    Ital Heart J; 2001 Nov; 2(11):801-3. PubMed ID: 11770861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerotic plaque burden, plaque vulnerability and arterial remodeling: the role of inflammation.
    Vink A; Pasterkamp G
    Minerva Cardioangiol; 2002 Apr; 50(2):75-83. PubMed ID: 12032461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation in atherothrombosis: how to use high-sensitivity C-reactive protein (hsCRP) in clinical practice.
    Ridker PM
    Am Heart Hosp J; 2004; 2(4 Suppl 1):4-9. PubMed ID: 15539969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.